プロフィール詳細

プロジェクトを作成

★★★★★

☆☆☆☆☆

★★★★★

☆☆☆☆☆

Dr. Laura E.に依頼

Spain

Medical Writer & Research Consultant | PhD & Immunology specialist | Clinical Scientist

プロフィール概要

I am a bilingual (EN/ES) medical writer and research consultant with a PhD in Immunology, combining hands-on clinical experience with strong expertise in biomedical research. I support biotech, pharma, and academic teams with high-quality scientific and medical writing, including literature reviews, evidence synthesis, and manuscripts. My background in both clinical practice and research allows me to accurately interpret clinical trial data, endpoints, and safety outcomes, and translate complex scientific information into clear, rigorous, and compliant medical content. I work across the full spectrum of medical writing, from systematic and narrative reviews to abstracts, posters, white papers, and scientific reports, as well as specialized medical translation EN↔ES.

専門分野

• ☆ Clinical Immunology
• ☆ Medical Writing

サービス

• Writing
• Research
• Consulting

Writing Medical Writing, Technical Writing

Research Scientific and Technical Research, Systematic Literature Review

Consulting Healthcare Consulting, Scientific and Technical Consulting

職務経験

Immunology Specialist

Eurofins

5月 2025 - 現在

Clinical Scientist

SYNLAB

2月 2024 - 5月 2025

medical expert

Eurofins

9月 2023 - 1月 2025

Senior Scientist

Hospital de la Princesa

5月 2020 - 9月 2023

Part-time specialist

SYNLAB

3月 2021 - 9月 2021

Clinical Residency in Immunology

Hospital de la Princesa

5月 2017 - 5月 2021

学歴

PhD in Immunology

Universidad Autonoma, España

5月 2020 - 12月 2023

BSc Biology

Universidad Complutense

9月 2009 - 6月 2014

認定資格

• 認定資格の詳細は未入力です。

出版物

JOURNAL ARTICLE

Pedro Martínez-Fleta, María Celeste Marcos, Daniel Jimenez-Carretero, José María Galván-Román, Rosa María Girón-Moreno, Ana Adela Calero-García, Ana Arcos-García, Enrique Martín-Gayo, Hortensia de la Fuente, Laura Esparcia-Pinedo, et al. (2024). Imbalance of SARS-CoV-2-specific CCR6+ and CXCR3+ CD4+ T cells and IFN-γ + CD8+ T cells in patients with Long-COVID . Clinical Immunology.

Ilya Tsukalov, Ildefonso Sánchez-Cerrillo, Olga Rajas, Elena Avalos, Gorane Iturricastillo, Laura Esparcia, María José Buzón, Meritxell Genescà, Camila Scagnetti, Olga Popova, et al. (2024). NFκB and NLRP3/NLRC4 inflammasomes regulate differentiation, activation and functional properties of monocytes in response to distinct SARS-CoV-2 proteins . Nature Communications.

Virginia Meca-Lallana, Laura Esparcia-Pinedo, Clara Aguirre, Carolina Díaz-Pérez, Ainhoa Gutierrez-Cobos, Mónica Sobrado, Estefanía Carabajal, Beatriz del Río, Noelia Ropero, Ramón Villagrasa, et al. (2023). Analysis of humoral and cellular immunity after SARS-CoV-2 vaccination in patients with multiple sclerosis treated with immunomodulatory drugs . Clinical Immunology Communications.

Laura Esparcia-Pinedo, Ángel Lancho-Sánchez, Ilya Tsukalov, María I. Pacheco, Pedro Martínez-Fleta, Belén Pérez-Miés, José Palacios-Calvo, Francisco Sánchez-Madrid, Enrique Martín-Gayo, Arantzazu Alfranca (2023). T regulatory lymphocytes specific for SARS-CoV-2 display increased functional plasticity . Clinical Immunology.

Laura Esparcia-Pinedo, Nuria Romero-Laorden, Arantzazu Alfranca (2023). Tertiary lymphoid structures and B lymphocytes: a promising therapeutic strategy to fight cancer . Frontiers in Immunology.

Laura Esparcia-Pinedo, Ayla Yarci-Carrión, Gloria Mateo-Jiménez, Noelia Ropero, Laura Gómez-Cabañas, Ángel Lancho-Sánchez, Patricia Almendro-Vázquez, Enrique Martín-Gayo, Estela Paz-Artal, Francisco Sanchez-Madrid, et al. (2023). Development of an Effective Immune Response in Adults With Down Syndrome After Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination . Clinical Infectious Diseases.

Ayla Yarci-Carrión, Laura Esparcia-Pinedo, Gloria Mateo-Jiménez, Arantzazu Alfranca, Diego Real de Asúa, Ainhoa Gutiérrez-Cobos (2023). Effect of a SARS-CoV-2 booster vaccine dose on the immune response of adults with Down syndrome . Journal of Infection.

Laura Esparcia-Pinedo, Pedro Martínez-Fleta, Noelia Ropero, Paula Vera-Tomé, Hugh T. Reyburn, José M. Casasnovas, José M. Rodríguez Frade, Mar Valés-Gómez, Carlos Vilches, Enrique Martín-Gayo, et al. (2022). CD4+ T Cell Immune Specificity Changes After Vaccination in Healthy And COVID-19 Convalescent Subjects . Frontiers in Immunology.

María C. Martín, Aurora Jurado, Cristina Abad-Molina, Antonio Orduña, Oscar Yarce, Ana M. Navas, Vanesa Cunill, Danilo Escobar, Francisco Boix, Sergio Burillo-Sanz, et al. (2021). The age again in the eye of the COVID-19 storm: evidence-based decision making . Immunity & Ageing.

Diego A. Rodríguez-Serrano, Emilia Roy-Vallejo, Nelly D. Zurita Cruz, Alexandra Martín Ramírez, Sebastián C. Rodríguez-García, Nuria Arevalillo-Fernández, José María Galván-Román, Leticia Fontán García-Rodrigo, Lorena Vega-Piris, Marta Chicot Llano, et al. (2021). Detection of SARS-CoV-2 RNA in serum is associated with increased mortality risk in hospitalized COVID-19 patients . Scientific Reports.

Ekaterina Marakasova, Ancha Baranova (2021). MMR Vaccine and COVID-19: Measles Protein Homology May Contribute to Cross-Reactivity or to Complement Activation Protection . mBio.

José María Galván-Román, Sebastián C. Rodríguez-García, Emilia Roy-Vallejo, Ana Marcos-Jiménez, Santiago Sánchez-Alonso, Carlos Fernández-Díaz, Ana Alcaraz-Serna, Tamara Mateu-Albero, Pablo Rodríguez-Cortes, Ildefonso Sánchez-Cerrillo, et al. (2021). IL-6 serum levels predict severity and response to tocilizumab in COVID-19: An observational study . Journal of Allergy and Clinical Immunology.

Ildefonso Sánchez-Cerrillo, Pedro Landete, Beatriz Aldave, Santiago Sánchez-Alonso, Ana Sánchez-Azofra, Ana Marcos-Jiménez, Elena Ávalos, Ana Alcaraz-Serna, Ignacio de los Santos, Tamara Mateu-Albero, et al. (2020). COVID-19 severity associates with pulmonary redistribution of CD1c+ DCs and inflammatory transitional and nonclassical monocytes . Journal of Clinical Investigation.